|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenograft 显示文摘 | Ishikawa T Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，7： | 1 |
| 2 | Capecitabine, a new oral fluoropyrimidine carbamate, selectively delievers florouracil to tumor tissues in human cancer X- enoyrafts 显示文摘 | Ishikawa T Utoh M Sawadanetal | 1998 | Biocherm pharmacal1998，9，5131： | 1 |
| 3 | Capecitabine, a new oral fluoropyrimidine carbamate, selectively delivers fluorouracil to tumor tissues in human cancer xenografts 显示文摘 | IshikawaT Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，3： | 1 |
| 4 | Tumor selective delivery of 5-fluurouracil by capecitabine, a new oral fluoropyrimidine carba- mate, in human cancer xenografts 显示文摘 | Ishikawa T Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，7： | 1 |
| 5 | Tumor selective delivery of 5 -Fura by capecitabine,a new oral fluoropyrimidine carbamate,in human cancer xenografts 显示文摘 | Ishikawa T Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，7： | 1 |
| 6 | Near completely humanized liver in mice shows human-type metabolic responses to drugs显示文摘 | Tateno C Yoshizane Y Saito N Kataoka M Utoh R Yamasaki C Tachibana A Soeno Y As | | 0，，03： | 1 |
| 7 | Capecitabine,a new oral fluoropyrimidine carbamate selectively delivers fluorouracil to tumor tissues in human cancer xenografts显示文摘 | Ishikawa T Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，： | 1 |
| 8 | Cell-type specific and thyroid hormone-dependent expression of genes of al (Ⅰ)and a2 (1) collagen in intestine during amphibian metamorphosis显示文摘 | Asahina K Utoh R Obara M | | 0，，01： | 1 |
| 9 | Tumor selective delivery of 5-fluorouracil by capecitabine,a new oral fluoropyrimidine carbamale,in human cancer xenografts 显示文摘 | Ishikawa T Utoh M Sauada N | 2003 | Biochem Pharmoco12003，55，7： | 1 |
| 10 | Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts 显示文摘 | Ishikawa T Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，7： | 1 |
| 11 | Capecitabine , a new oral fluoropyrimidine carbamate , selectively delivers fluorouracil to tumor tissues in human cancer xenografts 显示文摘 | Ishikawa T Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，3： | 1 |
| 12 | Tumor selective delivery of 5-fluorouracil by capecitabine,a new oral fluoropyrimidine carbamate in human cancer xenografts显示文摘 | Utoh M Sawads N | 1998 | Biochem pharma col1998，55，7： | 1 |
| 13 | Capecitabine , a new o- ral fluoropyrimidine carbamate, selectively delivers fluorouracil to tumor tissues in human cancer xenografts 显示文摘 | Ishikawa T Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，3： | 1 |
| 14 | Tumor selective delivery of 5-fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts显示文摘 | Ishikawa T Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，7： | 1 |
| 15 | Tumor seletive delivery of 5-fluorouraci显示文摘 | Ishikawa T Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，7： | 1 |
| 16 | Capecitabine,a new oral fluoropyrimidine carbamate selectively delivers fluorouracil to tumor tissues in human cancer xenografts显示文摘 | shikawa T Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，： | 1 |
| 17 | Tumor selective delivery nf 5 - fluorou racil by capecitabine,a new oral fluoropyrimidine carbamate in human cancer xenograrts 显示文摘 | Ishikawa T Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，7： | 1 |
| 18 | Tumor selective delivery of 5- fluorouracil by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts 显示文摘 | Ishikawa T Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，7： | 1 |
| 19 | Tumor selective delivery of 5-fluorouracil by capecitabine,a new oral fluoropyrimidine carbamate,in human cancer xenografts显示文摘 | Ishikawa T Utoh M Sawada N | 1998 | Biochem Pharmacol1998，55，： | 1 |
| 20 | Tumor selective delivery of 5-Fura by capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts显示文摘 | ISHIKAWA T UTOH M SAWADA N | 1998 | Biochem Pharmacol1998，55，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员